The vaccine comprised 6 mRNA molecules encoding for fixed tumor-associated antigens: Mucin1 (MUC1), survivin, NY-ESO-1, 5T4, MAGE-C2, and MAGE-C1, which are overexpressed in NSCLC compared to healthy tissue. The gene discussed is BIRC5; the disease is neoplasm.